imrMay 9, 2021
“Intel Market Report presents a comprehensive report on the ‘Genotyping Assay Market’ comprising all the key factors impacting the industry and the overall growth. They include the industry drivers, opportunities, challenges, prevailing trends, and restraints that help the business owners, marketing personnel, and stakeholders, and customers to plan effective strategies and achieve their short-term goals smoothly. The report involves extensive study of the historical data with detailed statistics to help the readers determine future scope of the Genotyping Assay market with respect to key opportunities. The updated report crucially inspects all the aspects in terms of production and consumption. This assists the readers and manufacturers to focus on production with complete information on consumption patterns of consumers, without excess production and reducing wastage and saving resources and raw materials.
4.3.2 Shifting Role of Diagnostics
4.3.3 Multiplexing and Foundation One
4.3.4 The Disruption Dynamic
4.3.6 The Next Five Years
5. Cancer Immuno-Oncology Diagnostics Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
Qiagen Expands Immuno-Oncology Portfolio
IncellDx Awarded PD-L1 Detection Patent
FDA Approves CDx for Trastuzumab
Promega Nabs CE Mark for Microsatellite Instability IVD
ArcherDx partners with AstraZeneca for Immuno-Oncology
Germline Results Guides Precision Therapy
Agilent PD-L1 Assay Gets FDA Approval
Bayer, OrigiMed Form Companion Diagnostic Development Alliance
Bio-Me to Develop Microbiome Biomarker Test for Cancer Immunotherapy
SkylineDx, BioInvent Collaborate to Characterize Predictive Immunological
Share this article
Share this article
ResearchAndMarkets.com s offering.
Sepsis was killing over 30 million people a year with no definitive diagnostic in hand. And now the COVID-19 Pandemic has increased the sepsis death toll. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life-saving diagnostics can command a premium in the market, especially deaths related to COVID-19 infections. Understand the different drivers of this huge global diagnostic market and where the opportunity lies.